Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: Impacting hERG liability via aryl modifications

被引:19
作者
McBriar, Mark D. [1 ]
Guzik, Henry [1 ]
Shapiro, Sherry [1 ]
Xu, Ruo [1 ]
Paruchova, Jaroslava [1 ]
Clader, John W. [1 ]
O'Neill, Kim [1 ]
Hawes, Brian [1 ]
Sorota, Steve [1 ]
Margulis, Michael [1 ]
Tucker, Kristal [1 ]
Weston, Daniel J. [1 ]
Cox, Kathleen [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
关键词
melanin concentrating hormone; hERG; MCH; obesity;
D O I
10.1016/j.bmcl.2006.05.069
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein, we report the discovery of an effective strategy to modulate liabilities related to affinity of previously disclosed bicyclohexane MCHR-1 antagonists for the hERG channel. This paper describes one of several strategies incorporated to limit hERG binding via modifications of a terminal aryl group in an otherwise promising bicyclohexyl urea series. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4262 / 4265
页数:4
相关论文
共 16 条
[1]   A high-throughput HERG potassium channel function assay: An old assay with a new look [J].
Cheng, CS ;
Alderman, D ;
Kwash, J ;
Dessaint, J ;
Patel, R ;
Lescoe, MK ;
Kinrade, MB ;
Yu, WF .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (02) :177-191
[2]   QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience [J].
De Ponti, F ;
Poluzzi, E ;
Montanaro, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (01) :1-18
[3]   Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats [J].
Della-Zuana, O ;
Presse, F ;
Ortola, C ;
Duhault, J ;
Nahon, JL ;
Levens, N .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (10) :1289-1295
[4]   Chronic intracerebroventricular infusion of MCH causes obesity in mice [J].
Gomori, A ;
Ishihara, A ;
Ito, M ;
Mashiko, S ;
Matsushita, H ;
Yumoto, M ;
Ito, M ;
Tanaka, T ;
Tokita, S ;
Moriya, M ;
Iwaasa, H ;
Kanatani, A .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (03) :E583-E588
[5]   Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance [J].
Ludwig, DS ;
Tritos, NA ;
Mastaitis, JW ;
Kulkarni, R ;
Kokkotou, E ;
Elmquist, J ;
Lowell, B ;
Flier, JS ;
Maratos-Flier, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :379-386
[6]   Melanin-concentrating hormone as a therapeutic target [J].
McBriar, MD ;
Kowalski, TJ .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 :119-133
[7]   Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas [J].
McBriar, MD ;
Guzik, H ;
Shapiro, S ;
Paruchova, J ;
Xu, R ;
Palani, A ;
Clader, JW ;
Cox, K ;
Greenlee, WJ ;
Hawes, BE ;
Kowalski, TJ ;
O'Neill, K ;
Spar, BD ;
Weig, B ;
Weston, DJ ;
Farley, C ;
Cook, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (07) :2294-2310
[8]   Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity [J].
Palani, A ;
Shapiro, S ;
McBriar, MD ;
Clader, JW ;
Greenlee, WJ ;
Spar, B ;
Kowalski, TJ ;
Farley, C ;
Cook, J ;
van Heek, M ;
Weig, B ;
O'Neill, K ;
Graziano, M ;
Hawes, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :4746-4749
[9]   Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel.: A model for bad behavior [J].
Pearlstein, R ;
Vaz, R ;
Rampe, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (11) :2017-2022
[10]   Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development [J].
Redfern, WS ;
Carlsson, L ;
Davis, AS ;
Lynch, WG ;
MacKenzie, I ;
Palethorpe, S ;
Siegl, PKS ;
Strang, I ;
Sullivan, AT ;
Wallis, R ;
Camm, AJ ;
Hammond, TG .
CARDIOVASCULAR RESEARCH, 2003, 58 (01) :32-45